Abbott Laboratories
Update in progressABT (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Abbott Laboratories and its subsidiaries discover, develop, manufacture, and sell healthcare products worldwide. It operates in four segments: Established Pharmaceuticals, Diagnostics, Nutritional Products, and Medical Devices. The company offers prescription medicines, diagnostics systems, laboratory and transfusion testing, molecular and point-of-care tests, rapid diagnostics, and screening products; plus nutrition, cardiovascular devices, diabetes care, and neuromodulation devices. Based in Abbott Park, Illinois.
Company score
- Sentiment
- -0.44
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.29
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -1.89
- Governance
- -2.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.91
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.68
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!